πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,152 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9205091

Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9205276

Light as a replacement for mitogenic factors on progenitor cells

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND SERVICES Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9198976

Polysaccharide-protein conjugate vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9198645

Controlled vesicle self-assembly in continuous two phase flow microfluidic channels

The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9193769

Bovine adeno-associated viral (BAAV) vector and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9193790

Use of antagonists of the interaction between HIV GP120 and A4B7 integrin

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9186406

Compositions containing nucleosides and manganese and their uses

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9186365

Antiangiogenic small molecules and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9181530

Infectious hepatitis E virus genotype 3 recombinants

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9181340

TEM8 antibodies, conjugates thereof, and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9180133

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9180179

Development of a marker foot and mouth disease virus vaccine candidate that is attenuated

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9181253

Adenosine receptor agonists, partial agonists, and antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9181306

Insertion of foreign genes in rubella virus and their stable expression in a live, attenua

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9181327

Anti-HIV domain antibodies and method of making and using same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175070

Neutralizing antibodies to HIV-1 and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175049

Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and prote

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175057

Immunogenic peptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175062

Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing h

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9173898

Methods of treating giardiasis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9173931

Process for preparing polysaccharide-protein conjugate vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9175038

Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9169297

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9169296

Expression and assembly of human group C rotavirus-like particles and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted